13FPulse
LL

LLY ELI LILLY & CO

2026Q2 · CUSIP 532457108 · GLP-1 / Weight Loss · Sector: Healthcare & Biotech

Piling in

Net holder growth ranks near the top of the market

Funds that own it
4,527
Institutions that reported holding it to the SEC
Net increase in holders
+157
Last quarter 4,370 → now 4,527
How unusual is that
Top 1% in the market
Stronger buying than 99.0% of US stocks
What the filings say, in one paragraph

4,527 funds held LLY at the end of 2026Q2, up 157 from the quarter before. That is stronger buying than 99.0% of US stocks — among the most piled-into names this quarter. On the business itself, revenue over the last 12 months was $79.7B(YoY +49.6%), the P/E is 38.9x, return on equity is 78.8%. LLY has had 38 buying rushes in its history, and the price moved +13.7% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector, tagged GLP-1 / Weight Loss.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2013Q3: holders=966 2013Q4: holders=998 2014Q1: holders=1022 2014Q2: holders=1020 2014Q3: holders=1036 2014Q4: holders=1125 2015Q1: holders=1111 2015Q2: holders=1134 2015Q3: holders=1142 2015Q4: holders=1215 2016Q1: holders=1144 2016Q2: holders=1173 2016Q3: holders=1171 2016Q4: holders=1215 2017Q1: holders=1253 2017Q2: holders=1250 2017Q3: holders=1226 2017Q4: holders=1376 2018Q1: holders=1336 2018Q2: holders=1370 2018Q3: holders=1428 2018Q4: holders=1556 2019Q1: holders=1608 2019Q2: holders=1511 2019Q3: holders=1525 2019Q4: holders=1671 2020Q1: holders=1683 2020Q2: holders=1763 2020Q3: holders=1772 2020Q4: holders=1887 2021Q1: holders=1949 2021Q2: holders=2018 2021Q3: holders=2049 2021Q4: holders=2306 2022Q1: holders=2348 2022Q2: holders=2444 2022Q3: holders=2480 2022Q4: holders=2663 2023Q1: holders=2617 2023Q2: holders=2810 2023Q3: holders=2972 2023Q4: holders=3268 2024Q1: holders=3461 2024Q2: holders=3565 2024Q3: holders=3661 2024Q4: holders=3906 2025Q1: holders=3921 2025Q2: holders=3911 2025Q3: holders=3901 2025Q4: holders=4437 2026Q1: holders=4370 2026Q2: holders=4527 -536 -268 +0 +268 +536 86928124754 13Q315Q116Q318Q119Q321Q122Q324Q125Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 38 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q2 Top 1% in the market
2025Q4 Top 1% in the market -0.3%
2025Q1 Top 20% -6.7% +35.8%
2024Q4 Top 1% in the market -10.1% -17.0%
2024Q3 Top 1% in the market +20.4% -1.3%
2024Q2 Top 1% in the market -14.7% -5.7%
2024Q1 Top 1% in the market +19.9% -2.8%
2023Q4 Top 1% in the market -1.4% +18.2%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
422
Change in large funds
+38
Total value they hold
$940.4B
Funds buying for the first time
408
Funds that sold out entirely
251
Price change that quarter
+17.4%
Funds holding puts (bearish)
83
Funds holding calls (bullish)
65

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
38.9
EPS (TTM)
$29.80
EPS YoY
+94.8%
Revenue (TTM)
$79.7B
Revenue YoY
+49.6%
Net margin
33.5%
ROE
78.8%
Debt ratio
76.2%
FCF (TTM)
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS 1.22 2021-12-31: EPS 1.88 2022-03-31: EPS 2.10 2022-06-30: EPS 1.05 2022-09-30: EPS 1.61 2022-12-31: EPS 2.14 2023-03-31: EPS 1.49 2023-06-30: EPS 1.95 2023-09-30: EPS -0.06 2023-12-31: EPS 2.42 2024-03-31: EPS 2.48 2024-06-30: EPS 3.28 2024-09-30: EPS 1.07 2024-12-31: EPS 4.88 2025-03-31: EPS 3.06 2025-06-30: EPS 6.29 2025-09-30: EPS 6.21 2025-12-31: EPS 7.39 2026-03-31: EPS 8.26 2026-06-30: EPS 7.94 0B 11.5B 23.0B $B -0.07 4.51 9.09 2016201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 61 32 86 139 20222023202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
0K1.1B2.2B 20192020202120222023202420252026
Latest quarter $1.6B (2022-09-30)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.